Meeting Public Comments

Subcommittee meeting and times are as follows:
Attendance at subcommittee meetings by lobbyists and the public is via zoom or in-person. See agenda for zoom details. Only authenticated users are permitted access.
A bill for an act relating to the medical cannabidiol program including medical cannabidiol dispensaries.
Subcommittee members: Reichman-CH, Evans, Petersen
Date: Tuesday, February 7, 2023
Time: 11:30 AM - 12:00 PM
Location: Room 217 Conference Room
Comments Submitted:
The purpose of comments is to provide information to members of the subcommittee.
Names and comments are public records. Remaining information is considered a confidential record.

Carl Olsen [Iowans for Medical Marijuana]
We should be seeking a federal exemption under 21 U.S.C. Section 822(d) for these manufacturers and distributors, so consumers are protected by 21 U.S.C. Section 822(c)(3). The legislature needs to address this. The limited number of manufacturing the distribution licenses make it unlikely anyone without the intent to violate federal drug law will even bother to apply. Since when did it become the policy of our state to promote violation of federal drug law?